Join our community of smart investors

Covid-19 brings generics to the fore

Hikma Pharmaceuticals has supplied various of the medicines used to treat virus patients
Covid-19 brings generics to the fore
  • FTSE 100 company Hikma is due to report full-year numbers on 25 February
  • The coronavirus crisis has shone an even brighter spotlight on the plus-points of cheap, easily accessible medicine
IC TIP: Buy at 2377p

In a rare coup for Downing Street during the Covid-19 saga, more than 15m people have now been vaccinated against the deadly virus. This puts the UK well ahead of other Western economies where jab rollouts have been hampered by bureaucracy and supply issues. Yet Boris Johnson has urged caution. “This is an unprecedented national achievement but it’s no moment to relax”, the Prime Minister said at a briefing on 15 February.

To continue reading...
OR
Register for free
Read 3 articles for free each month
* Excl. premium articles
Have an account? Sign in